Hematology News

The FDA approved deferiprone for treatment of children or adults with transfusional iron overload due to sickle cell disease or other anemias.

Treatment with tranexamic acid significantly reduced the incidence of calculated estimated postpartum blood loss of more than 1000 mL or red‐cell transfusions within 2 days of cesarean delivery, according to a randomized controlled trial.

Patients with cancer appeared at increased risk for arterial thromboembolism and mortality within 1 year of cancer diagnosis compared with the general population, according to an epidemiological analysis published in JACC: CardioOncology.

Patients with cancer may be at high risk for venous thromboembolism and arterial thromboembolic events while undergoing treatment with immune checkpoint inhibitors, according to study results published in Blood.

Nearly one-third of patients with atrial fibrillation and/or venous thromboembolism treated with a direct oral anticoagulant, or DOAC, were also using aspirin without clear indications, researchers reported.

Brian Bolwell, MD, FACP, has been appointed chair of physician leadership and development in the Mandel Global Leadership and Learning Institute at Cleveland Clinic.

Compared with aseptic revision total knee replacement, revision for periprosthetic joint infection or fracture doubles the risk for postoperative venous thromboembolism, according to the published results.

More than one-quarter of patients with COVID-19 had elevated D-dimer levels up to 4 months after diagnosis, according to study results published in Journal of Thrombosis and Haemostasis.

Gender‐affirming hormone therapy appeared to increase overall procoagulant profiles among transgender women but not transgender men, according to study results published in Journal of Thrombosis and Haemostasis.

Patients hospitalized with severe and non-severe COVID-19 appeared at increased risk for symptomatic venous thromboembolism, according to study results published in Journal of Thrombosis and Haemostasis.